Back to News

Amazon Continues Its Focus on Empowering India’s AI Talent, Launches Fifth Edition of Its Machine Learning Summer School

Analytics Insight
Jul 22, 2025 11:00
Analytics Insight
1 views
aianalyticsbig-databusiness

Summary

Amazon has launched the fifth edition of its Machine Learning Summer School in India, aiming to equip students with advanced AI and machine learning skills. This initiative reflects Amazon's ongoing commitment to nurturing local AI talent and strengthening India's position in the global AI landscape. The program is expected to help bridge the skills gap and foster innovation in the field.

Read Full ArticleMore News

Related Articles

XRP vs Chainlink: Which Crypto Could Make You a Millionaire?

Analytics InsightJul 22

The article compares XRP and Chainlink, analyzing their potential to generate significant returns for investors. While primarily focused on cryptocurrency investment, it highlights how Chainlink’s AI-driven smart contract capabilities could play a pivotal role in the future of decentralized finance. This suggests that advancements in AI integration with blockchain technology may influence the success and adoption of such digital assets.

Skipped Early Cardano (ADA)? Don’t Miss Ruvi AI’s (RUVI) Audited Token While Still Cheap, Experts Say It’s Next to Rally

Analytics InsightJul 22

The article highlights Ruvi AI's (RUVI) audited token as a promising investment opportunity in the AI sector, drawing comparisons to the early days of Cardano (ADA). Experts suggest that RUVI's low current price and recent audit position it for significant growth, signaling increasing investor interest in AI-driven blockchain projects. This trend underscores the growing convergence of AI and blockchain technologies in the crypto market.

AI-Designed Drugs Can Target 'Undruggable' Proteins in Cancer and Alzheimer's

Hacker News - AIJul 22

AI-driven drug discovery is enabling the design of molecules that can target previously "undruggable" proteins involved in diseases like cancer and Alzheimer's. This breakthrough expands the range of treatable conditions and demonstrates AI's transformative potential in accelerating and broadening pharmaceutical innovation.